Prof. Giovanni Traverso is the Director of the Laboratory for Translational Engineering (www.l4te.org), Associate Professor in the Department of Mechanical Engineering at the Massachusetts Institute of Technology (MIT), a gastroenterologist in the Division of Gastroenterology, Brigham and Women’s Hospital (BWH), Harvard Medical School and an Associate Member of the Broad Institute. Dr. Traverso grew up in Peru, Canada and the United Kingdom. He received his BA from Trinity College, University of Cambridge, UK, and his PhD from the lab of Prof. Bert Vogelstein at Johns Hopkins University. He subsequently completed medical school at the University of Cambridge, internal medicine residency at the Brigham and Women’s Hospital and his gastroenterology fellowship training at Massachusetts General Hospital, both at Harvard Medical School. Dr. Traverso’s previous work focused on the development of novel molecular tests for the early detection of colon cancer. For his post-doctoral research, he transitioned to the fields of chemical and biomedical engineering in the laboratory of Professor Robert Langer at MIT where he developed a series of novel technologies for drug delivery as well as physiological sensing via the gastrointestinal tract.
His current research program integrates engineering and medicine to create the next generation of biomedical technologies. Efforts span advanced drug delivery systems, ingestible and implantable devices, and biocompatible materials designed to improve adherence and enable new therapeutic modalities. His group is also pioneering robotic and electroceutical approaches for closed-loop sensing and treatment, as well as platforms for nucleic acid and cell therapy delivery. Beyond therapeutics, the lab is advancing diagnostic and biosensing tools for early disease detection and real-time monitoring of human physiology, with the broader goal of transforming how diseases are prevented, detected, and treated.
Researchers including Assistant Professor Giovanni Traverso have designed a new face mask that could stop viral particles as effectively as N95 masks. and can be easily sterilized and used many times.
A team of researchers including Assistant Professor Giovanni Traverso developed a kirigami-inspired stent system that can support the rapid delivery of drugs to long tubular organs like the gastrointestinal tract.
A team of researchers including Assistant Professor Giovanni Traverso have developed an ingestible capsule capable of delivering antibodies, insulin and other drugs which usually require an injection.
Trinity College, University of Cambridge
B.A.Johns Hopkins University
Ph.D.Trinity College, University of Cambridge
M.B., B.Chir.Ingestible and implantable robotics
Biocompatible smart materials
Translational science
Drug delivery for optimal drug adherence
Biomedical device development
Early detection of cancer
“Inactive ingredients” and their potential benefits and harms
LinkedIn: https://www.linkedin.com/in/giovanni-traverso-84386742/
Google Scholar: https://scholar.google.com/citations?user=Htybq6sAAAAJ&hl=en
PubMed – My Bibliography: https://www.ncbi.nlm.nih.gov/myncbi/carlo.traverso.1/bibliography/public/
2002 Collegiate Inventors Competition
2002 Research Fellowship, Trinity College, University of Cambridge
2003 MIT TR100
2016 Inventions Award, Popular Science
2022 Fellow, Controlled Release Society College of Fellows
2023 Fellow, National Academy of Inventors
2024 Fellow, American Institute for Medical and Biological Engineering
2025 Académie royale de Médecine de Belgique, Membre étranger
Medical Device Design (2.750) - Fall 2019, Fall 2020, Spring 2022, Spring 2023, Spring 2024, Spring 2025
Translational Engineering (2.S988) - Spring 2020, Spring 2021, Fall 2022, Fall 2024
Mechanics & Materials (2.001) - Fall 2021
Google Scholar: https://scholar.google.com/citations?hl=en&user=Htybq6sAAAAJ
NCBI My Bibliography: https://www.ncbi.nlm.nih.gov/myncbi/carlo.traverso.1/bibliography/public/